FATIMA ALI

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease BETHLEHEM, PA NPI 1013366368

General Payments — all program years on this page

$21,473.78

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $533.93 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $533.9315

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $136.822
2020 $101.401
2021 $236.102
2022 $10,193.085
2023 $10,272.454
2024 $533.9315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086759701 Novartis Pharmaceuticals Corporation $17.94 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087845598 Pulmonx Corporation $20.53 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087845600 Pulmonx Corporation $116.88 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087845602 Pulmonx Corporation $26.59 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087845604 Pulmonx Corporation $146.33 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089569205 Insmed, Inc. $18.74 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105519257 AstraZeneca Pharmaceuticals LP $17.74 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111513969 Amgen Inc. $30.03 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113890116 Paratek Pharmaceuticals, Inc. $17.07 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113997356 Regeneron Healthcare Solutions, Inc. $14.71 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116435003 GlaxoSmithKline, LLC. $14.50 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117836662 Boehringer Ingelheim Pharmaceuticals, Inc. $21.28 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117836664 Boehringer Ingelheim Pharmaceuticals, Inc. $23.20 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137467357 Takeda Pharmaceuticals U.S.A., Inc. $34.64 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147316391 Mylan Specialty L.P. $13.75 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.